Orginal from: PR Newswire
Copan Diagnostics, a leader in microbiology laboratory innovations, is proud to announce that UriSponge®, a urine collection and transport device which uses a new formulation of advanced preservatives to ensure specimen stability for culture, has received clearance from the U.S. Food and Drug Administration (FDA). The solution offers clinical laboratories and healthcare providers a user-friendly, reliable, and cost-effective way to improve urine specimen collection, preservation, and transport.
"Copan is dedicated to advancing laboratory practices through groundbreaking innovation," said Fabrizio Mazzochi, CEO of Copan Diagnostics. "UriSponge® provides a reliable and efficient solution that supports laboratory needs while offering healthcare providers a safe, streamlined process."
Unique System for Urine Specimen Preservation
Urine samples constitute nearly 70% of specimens processed annually in clinical laboratories. Urine specimens are collected and processed to cultivate uropathogenic bacteria and yeasts. UriSponge® enables urine transfer from sterile container to tube using a quick dip-and-close method reducing steps and improving workflow.
The system features a screw-cap tube with a plastic applicator and sponges loaded with preservatives. Upon contact with urine, these preservatives maintain sample stability during transport, providing dependable results and minimizing the risk of contamination or degradation. The unique design ensures accurate sample preservation without requiring precise fill lines or additional mixing, reducing complexity and the use of extra consumables.
UriSponge® is designed with advanced preservatives to ensure specimen integrity, offering an alternative to traditional methods that require stringent handling protocols.
Automation Compatible
UriSponge® integrates seamlessly with laboratory automation such as Copan's WASP® Walk-Away Specimen Processor, which automates essential microbiology specimen processing tasks, including planting and streaking. UriSponge® and Copan's full laboratory automation solution offer a streamlined approach to specimen handling from collection through analysis, aimed at enhancing laboratory productivity and consistency.
Source: Copan Diagnostics Announces FDA Clearance for Innovative Urine Collection Device
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.